A number of nucleotide residues in ribosomal RNA (rRNA) undergo specific posttranscriptional modifications. The roles of most modifications are unclear, but their clustering in functionally important regions of rRNA suggests that they might either directly affect the activity of the ribosome or modulate its interactions with ligands. Of the 25 modified nucleotides in Escherichia coli 23S rRNA, 14 are located in the peptidyl transferase center, the main antibiotic target in the large ribosomal subunit. Since nucleotide modifications have been closely associated with both antibiotic sensitivity and antibiotic resistance, loss of some of these posttranscriptional modifications may affect the susceptibility of bacteria to antibiotics. We investigated the antibiotic sensitivity of E. coli cells in which the genes of 8 rRNA-modifying enzymes targeting the peptidyl transferase center were individually inactivated. The lack of pseudouridine at position 2504 of 23S rRNA was found to significantly increase the susceptibility of bacteria to peptidyl transferase inhibitors. Therefore, this indigenous posttranscriptional modification may have evolved as an intrinsic resistance mechanism protecting bacteria against natural antibiotics.
Posttranscriptional modifications in ribosomal RNA (rRNA) are ubiquitous. However, the functional significance of most of them remains obscure. Acquisition and maintenance through the course of evolution of a number of genes dedicated to rRNA modification in spite of the associated energetic and metabolic cost argue that the modified nucleotides in rRNA render competitive benefits for the species. Clustering of the modified nucleotides in the functional centers of the ribosome hints that some of them may help fine-tune ribosome functions. Indeed, inactivation of certain modification enzymes was shown to either decrease the efficiency of protein synthesis or negatively affect ribosome assembly. [1] [2] [3] [4] [5] However, in most cases, the lack of individual posttranscriptional modifications only marginally affects cell growth. 6, 7 The ribosome is one of the evolutionarily preferred antibiotic targets. A large variety of natural antibiotics of microbial origin bind to the ribosomes of sensitive organisms and inhibit protein synthesis, thereby providing competitive advantage to the antibiotic producers. One of the common ways through which antibiotic producers avoid suicide is by expressing specific methyltransferase enzymes that modify rRNA residues in the drug target site and thus prevent antibiotic binding to the ribosome. 8, 9 Acquisition of such genes by pathogens is one of the major causes of clinical resistance to a number of antibacterial drugs. However, not only acquisition of new rRNA modifications but also the lack of natural modifications may affect susceptibility of cells to antibiotics. In a few well-documented cases, the lack of natural modifications was shown to render cells resistant to specific antibiotics. [10] [11] [12] Most of the antibiotics that inhibit functions of the large ribosomal subunit act upon the peptidyl transferase center (PTC), the main catalytic site in the ribosome. The PTC is formed primarily by segments of domain V of 23S rRNA, which are targeted by many rRNA-modifying enzymes. Of the 25 posttranscriptional modifications mapped in Escherichia coli 23S rRNA, 14 modified nucleotides are located in domain V (Fig. 1) . 21, 22 Genes responsible for 8 of these modifications are known. In this study, we investigated which of these PTC modifications affect the susceptibility of the bacterial cell to PTC-targeting antibiotics.
Inactivation of rluC dramatically increases susceptibility of the cell to PTC-targeting antibiotics E. coli strains with individually inactivated genes of eight rRNA-modifying enzymes that target PTC (RluB, RluC, RluE, RluF, RlmB, RlmE, RlmL, and RlmN) were acquired from the Keio collection. 23 Except for the rlmE gene, inactivation of the genes encoding the modifying enzymes did not notably affect growth of E. coli in LB medium; rlmE inactivation resulted in a moderate (two-fold) reduction in cell growth rate (data not shown).
Comparison of susceptibility of the strains to seven PTC inhibitors showed that the lack of most posttranscriptional modifications had a small (one dilution or less) effect on the minimal inhibitory concentrations (MICs) of some of the drugs ( Table 1) . The notable exception was the strain in which RluC was inactivated. Cells lacking this enzyme showed increased susceptibility to all the tested PTC inhibitors. Furthermore, in the rluC − strain, susceptibility to some antibiotics increased dramaticallyup to 16-fold. This effect was clearly specific to the Fig. 1 . Secondary structure of the central loop segment of domain V of E. coli 23S rRNA. 13 Posttranscriptionally modified residues are shown in boldface and indicated by arrows (when the enzyme responsible for the modification is known) or arrowheads (when the corresponding enzyme is yet unknown). Enzymes responsible for individual modifications have been described previously. 7, [14] [15] [16] [17] [18] [19] [20] Two of three RluC targets are located in domain V (positions 2504 and 2580). Ψ2504, whose presence renders cells resistant to several peptidyl transferase-targeting antibiotics, is encircled.
PTC-targeting antibiotics because rluC inactivation had no effect on the MIC of streptomycin, an antibiotic that targets the small ribosomal subunit ( Table 1) .
The modification status of U2504 in the PTC affects sensitivity to antibiotics
In contrast to most bacterial rRNA-modifying enzymes that target one specific nucleotide, RluC converts three uridine residues in 23S rRNA (at positions 955, 2504, and 2580) to pseudouridines. 14, 15 In order to identify the specific residue that was responsible for the observed hypersusceptibility effects we mutated two of the U residues targeted by RluC, U955 and U2580, to C. These residues are involved in formation of Ψ-G base pairs, and their mutation to C does not disrupt the general base pairing scheme in the corresponding rRNA regions. The mutations were introduced in the pLK35 plasmid, 24 and the resulting plasmid, pUCUC (Amp r ), was introduced in the strain SQ171. In this strain, all the chromosomal rrn alleles are inactivated and wild-type rRNA is expressed from the rrn genes present on the pCSacB plasmid (Kan r ) 25, 26 (S. Quan and C. L. Squires, personal communication). After plasmid exchange, the selected Amp r /Kan s strain carrying the pUCUC plasmid expressed only mutant ribosomes with the U-to-C transitions at positions 955 and 2580 in 23S rRNA, as verified by primer extension (data not shown). SQ171 cells expressing mutant 23S rRNA from the pUCUC plasmid grew with a doubling time similar to that of cells carrying the wild-type pLK35 plasmid. Furthermore, the mutations U955C and U2580C on their own had only a small effect on antibiotic sensitivity ( Table 1) .
The rluC gene in the SQ171 cells expressing mutant ribosomes was then inactivated by transducing the rluC∷kan allele from the corresponding strain in the Keio collection. 27 In this strain, inactivation of rluC affected the conversion of only a single uridine residue (U2504) to pseudouridine, as verified by primer extension (Fig. 2) . The lack of this single-nucleotide modification significantly increased susceptibility of the cells to PTC-targeting inhibitors. The most pronounced effects in comparison with the rluC + control were observed with clindamycin (16-fold), linezolid (8-fold), and tiamulin (4-fold) ( Table 1) .
Antibiotic resistance could drive acquisition and maintenance of some rRNA modification enzymes
Our results reveal that one specific posttranscriptional modification in the PTC of the E. coli ribosome, conversion of U2504 to Ψ, notably increases cell resistance to several antibiotics. This 23S rRNA residue is exposed in the PTC active site, and it is a component of the binding site of several PTC-targeting inhibitors. [29] [30] [31] [32] [33] The importance of the U2504 modification for ribosome function is uncertain. Inactivation of rluC produces no discernible change in the bacterial growth at several tested laboratory conditions 14, 15 (and our data). Furthermore, although rluC is found in genomes of various α-proteobacteria, it is not universally conserved and many bacterial species (as well as most archaea and eukaryotes) lack the gene, arguing that the ribosome can efficiently carry protein synthesis without pseudouridylation of U2504. Thus, no information that would link RluC, and, more specifically, Ψ2504, to any particular ribosomal function currently exists.
Many natural antibiotics that bacteria might encounter in the environment target the PTC. Resistance to Table 1 . MICs (μg/ml) of antibiotics for the E. coli strains lacking individual rRNA-modifying enzymes a All tested antibiotics, except for streptomycin, which was used as a control, target the PTC in the large ribosomal subunit. b All MIC's were tested using the microbroth dilution procedure in 96-well plates.
these antibiotics, especially if it comes without loss of fitness, should notably benefit the cell. Therefore, it is conceivable that certain rRNA modification mechanisms could be gained and retained in the course of evolution as a way of protecting the ribosome from the action of these inhibitors. From our data, it appears that among other indigenous rRNA-modifying enzymes acting upon the nucleotides in the PTC, RluC is the best candidate for this role.
RluC could have originally evolved in a microbial producer of one of the protein synthesis inhibitors and then was 'snatched' by other organisms. Alternatively, it could have evolved or is still evolving from one of the cellular pseudouridine synthases that generate specific Ψ residues for the sake of improving ribosome function. In contrast to most bacterial rRNA modification enzymes that show high specificity and target one specific rRNA position, RluC modifies three uridine residues in the E. coli ribosome, all located at a notable distance from one another in the ribosome spatial structure and within seemingly divergent rRNA structural motifs. It is unclear whether the main function of the RluC enzyme is to modify only one of the three U residues (U2504?) and if the two other modifications are simply a result of RluC promiscuity or if RluC has been evolutionarily optimized to target all three of the residues it acts upon.
In conclusion, we believe that our data illuminate the possibility that some of the indigenous posttranscriptional modifications of rRNA can be viewed as intrinsic antibiotic resistance mechanisms. It is generally possible that even those rRNA modifications that today play a functional role in translation the modern ribosome could have been originally acquired as a means of protection against natural antibiotics. Fig. 2 . Status of the U2504 modification in the strains expressing 23S rRNA with the U955C and U2580C mutations. The strain SQ171 lacking chromosomal rrn alleles 26 was transformed with either pLK35 plasmid expressing wild-type rRNA or plasmid pUCUC carrying an rrnB operon with the mutations U955C and U2580C in the 23S rRNA gene. After plasmid exchange and verification that the strain exclusively expresses mutant ribosome, the rluC∷kan allele was transduced from the strain JW1072 from the Keio collection. 23 The status of U2504 modification was verified using the procedure of Ofengand et al. 28 based on selective modification of pseudouridine residues by CMC [N 3 -1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide]. Samples modified (+) and those not modified (−) with CMC are indicated. G, A, U, and C represent sequencing lanes. Note the lack of the CMC-modified band at position 2504 in the RNA sample prepared from the rluC − derivative of SQ171 cells expressing U955C/U2580C double-mutant 23S rRNA. Ψ residue at position 2457, which is introduced by RluE, remains unaffected.
